Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)

Heart Failure Clinical Trial

Official title: Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study)

Status Active, not recruiting

Clinical Trial Summary

Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study) is a large, prospective, hospital-based cohort study to investigate the following:

• Characteristics of patients with chronic heart failure and prognostic risks of these patients.

• Characteristics of patients with high risk for heart failure and critical factors which predict the development of symptomatic heart failure in these patients.

• The incidence and prognostic impact of metabolic syndrome in patients with chronic heart failure.

• The association between metabolic syndrome and the development of symptomatic heart failure.

Clinical Trial Description

The CHART-2 Study is a multicenter prospective observational cohort study identifying the characteristics, mortality and prognostic risks of patients with overt HF and patients without HF but who are at high risk for disease progression of cardiovascular diseases (CVD).

The purposes of the study are as follows:

1. to elucidate characteristics of patients with overt HF and the associated prognostic risks

2. to elucidate characteristics of patients at risk for HF and the factors associated with CVD progression

3. to elucidate factors associated with the development of AHFS

4. to elucidate prevalence and prognostic impact of metabolic syndrome (MetS) in patients with overt HF

5. to elucidate the association between MetS and the development of AHFS

6. to elucidate the prevalence and prognostic impact of malignancy in patients with CVD

7. to elucidate the prevalence of patients needing home nursing care and the characteristics of bedridden patients with CVD. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Cardiomyopathies
• Coronary Artery Disease
• Coronary Disease
• Heart Failure
• Heart Valve Diseases
• Hypertrophy
• Hypertrophy, Left Ventricular
• Left Ventricular Hypertrophy

• NCT number: NCT00418041
• Study type: Observational
• Source: Tohoku University
• Status: Active, not recruiting
• Phase: N/A
• Start date: October 2006
• Completion date: December 2019